Literature DB >> 3504085

Induction of megakaryocytic characteristics in human leukemic cell line K562: polyploidy, inducers, and secretion of mitogenic activity.

J F Leary1, B A Farley, R Giuliano, B A Kosciolek, S La Bella, P T Rowley.   

Abstract

Because of the rarity of megakaryocytes in the bone marrow, a cell line inducible for megakaryocytic characteristics provides a valuable model for study. When cultured with phorbol esters, the human multipotent hematopoietic leukemic cell line K562 can be induced to develop many megakaryocytic characteristics, viz. increased cell size, reduced growth rate, megakaryocytic antigens, and expression of the sis proto-oncogene, the structural gene for the B-chain of platelet-derived growth factor. Further aspects of this process are here presented. First, it induces the release of mitogenic activity into the medium. Second, phorbol dibutyrate induces polyploidy, a feature of normal megakaryocyte development. Third, mezerein and teleocidin, nonphorbol ester tumor promotors, also induce development of multinuclearity and polyploidy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3504085

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  3 in total

1.  Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.

Authors:  A J Sytkowski; C O'Hara; G Vanasse; M J Armstrong; S Kreczko; N Dainiak
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo.

Authors:  J C Keutzer; A J Sytkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

3.  Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release.

Authors:  Yuki Ishii; May Keu Nhiayi; Edison Tse; Jonathan Cheng; Michele Massimino; Donald L Durden; Paolo Vigneri; Jean Y J Wang
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.